Analysis – Goldea Capital

LIFT Provides Update on Timetable for Combination Transaction With Winsome Resources

Written by Customer Service on May 11, 2026. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) further to its press release dated May 5, 2026, is pleased to provide an update on the anticipated timetable in respect of the proposed combination transaction with Winsome Resources Limited (ASX: WR1; “Winsome”), pursuant to which LIFT will acquire all of the outstanding Winsome shares under a share scheme of arrangement (“Share Scheme”) and all of the outstanding Winsome options under a related option scheme of arrangement (“Option Scheme” and together, the “Schemes”), in exchange for the issue of new LIFT shares and LIFT CDIs, with the LIFT CDIs to be quoted on the Australian Securities Exchange. On May 11, 2026, the Supreme Court of Western Australia (“Court”) made orders approving...

Satellogic Reports First Quarter 2026 Financial Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Q1 2026 Revenue Increased 80% Year-over-Year to $6.1 Million Operating Loss Improved 33% Year-over-Year; Adjusted EBITDA Loss Improved 32% Signed $12 Million Agreement to Deliver In-Orbit NewSat Satellite to Sovereign Defense Customer Introduced Merlin AI-First Defense Constellation and Launched Aleph Observer; Expanded U.S. Defense and Intelligence Partnerships Ended Q1 with $121.9 Million in Cash and Cash Equivalents Management to Host Webcast and Conference Call May 12, 2026 at 8:00 a.m. ET NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) — Satellogic Inc. (NASDAQ: SATL), a vertically integrated geospatial intelligence platform delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today reported its financial results for the first quarter ended March 31, 2026. “Q1 2026 marked a clear operational...

K92 Mining Announces Strong Q1 2026 Financial Results – Record Quarterly Revenue, Net Income, Operating Cash Flow, EBITDA and Net Cash Position

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three months ended March 31, 2026. ProductionStrong quarterly production of 46,743 ounces gold equivalent (“AuEq”)(1) or 44,022 oz gold, 1,696,714 lbs copper and 38,845 oz silver, in line with budget. The Company reiterates its 2026 annual production guidance of 190,000 to 225,000 oz AuEq. Net of by-product credit basis cash costs of $785/oz gold and all-in sustaining costs (“AISC”) of $1,421/oz gold(2), co-product basis cash costs of $991/oz AuEq and AISC of $1,587/oz AuEq(2). Quarterly ore processed of 142,017 tonnes, a 37% increase from Q1 2025, with a head grade of 10.9 grams per tonne (“g/t”) AuEq, or 10.2 g/t gold, 0.6% copper and 11 g/t silver, with...

Microvast Reports First Quarter 2026 Financial Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

STAFFORD, Texas, May 11, 2026 (GLOBE NEWSWIRE) — Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced today its unaudited consolidated financial results for the first quarter ended March 31, 2026 (“Q1 2026”). “Our first quarter results reflect a period of strategic agility as we navigate evolving geopolitical dynamics and a shifting global landscape. While revenue of $60.6 million was impacted by delivery timing and regional headwinds in APAC, our resilient gross margin of 31.6% underscores the value of our technology and our ability to maintain strong positioning. We are entering a pivotal phase for Microvast with the launch of our 290Ah cell-based battery packs that we expect to integrate into the KAF electric powertrain solution and the ongoing...

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

Written by Customer Service on May 11, 2026. Posted in Public Companies.

•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY), a global leader in pharmaceutical manufacturing, today announced that they had entered into a definitive agreement in which MacroGenics will sell its good manufacturing practice (GMP) drug substance manufacturing operations to Bora, subject to customary closing conditions. “When MacroGenics articulated its strategic priorities last year, we committed to building a more focused company...

BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026

Written by Customer Service on May 11, 2026. Posted in Public Companies.

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the first quarter of 2026 by conference call on Friday, May 15, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference by navigating to: https://dpregister.com/sreg/10209272/104069d5d88. Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730....

3D Systems Reports First Quarter 2026 Financial Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

ROCK HILL, S.C., May 11, 2026 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2026.Q1 2026 revenue of $95.5 million increased 1% year-over-year, or 11% excluding the impact of divestitures, driven by strong performance in the Healthcare business and double‑digit growth across key markets, including Dental, Med Tech, and Aerospace & Defense. GAAP EPS loss narrowed to $(0.03), or $(0.01) on a non-GAAP basis, while Adjusted EBITDA improved to $2.1 million, reflecting the benefits of higher sales volumes and continued execution of cost reduction initiatives. Robust growth in Dental and Med Tech, each exceeding approximately 20% year-over-year, drove Healthcare to a scale that now rivals the Company’s Industrial segment. Early success of recently...

Liberty Gold Reports Q1 2026 Financial and Operating Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”), is pleased to announce its financial and operating results for the quarter ended March 31, 2026. All amounts are presented in United States dollars unless otherwise stated. FIRST QUARTER OF 2026 AND RECENT HIGHLIGHTS PROJECT HIGHLIGHTS – BLACK PINE During early 2026, Liberty Gold advanced the Black Pine Gold Project (“Black Pine” or the “Project”) through resource growth, continuation of a feasibility study, and key federal permitting milestones, while also executing strategic corporate initiatives.On April 3, 20261, we reported that the United States Forest Service published a Notice of Intent in the Federal Register to prepare an Environmental Impact Statement for Black Pine, initiating...

Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Successfully completed chronic toxicology studies for icovamenib, providing the nonclinical support for advancing to chronic clinical dosing, beyond the 12-week clinical dosing that has been used to date Topline data reported from the Phase II COVALENT-112 clinical trial of icovamenib in type 1 diabetes (“T1D”), supporting proposed mechanism of action First patients dosed in the Phase II COVALENT-211 and COVALENT-212 clinical trials of icovamenib in type 2 diabetes (“T2D”); both trials are on track with topline 26-week data expected in the fourth quarter of 2026 The Phase I GLP-131 (BMF-650) obesity clinical trial is on track; initial 28-day weight reduction data expected in the second quarter of 2026 Cash runway projected into the first quarter of 2027SAN CARLOS, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”...

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Written by Customer Service on May 11, 2026. Posted in Public Companies.

Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary(1)Net revenue increased 19% to $27.8 million, compared to $23.4 million in the first quarter of 2025. Gross profit of $25.9 million, or 93% of net revenue, compared to gross profit of $21.6 million, or 92% of net revenue, in the first quarter of 2025. Operating...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals